Snapshot from Jul 28, 2026 at 07:00 UTC. For live data and tracking: View Live
Accidents disease outbreak

Congo Ebola outbreak fastest-growing

Analysis based on 37 articles · First reported Jul 06, 2026 · Last updated Jul 23, 2026

Sentiment
-60
Attention
6
Articles
37
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The outbreak heightens demand for Ebola treatments and vaccines, benefiting companies like NanoViricides, Gilead Sciences, and Mapp Biopharmaceutical. However, the humanitarian crisis and regional instability may negatively impact local economies and increase healthcare costs.

pharmaceuticals healthcare

The Democratic Republic of the Congo is experiencing the fastest-growing Ebola outbreak in history, caused by the rare Bundibugyo virus with no approved vaccines or treatments. As of July 23, 2026, over 2,473 infections and 1,031 deaths have been reported across five provinces, including Ituri and Kisangani, with cases also in Uganda. The World Health Organization declared a Public Health Emergency of International Concern on May 17. The outbreak is complicated by attacks on healthcare workers, strikes by unpaid staff, rebel activity, and misinformation. The United States — Centers for Disease Control and Prevention warns of potential escalation. NanoViricides has received approval from the DRC Pillar Committee for a Phase II trial of NV-387 Oral Gummies, a broad-spectrum antiviral. The WHO has begun a study of remdesivir (Gilead Sciences) and MBP134 (Mapp Biopharmaceutical). The U.S. CDC models suggest 10,000-20,000 cases in the next three months.

92 Democratic Republic of the Congo warned of outbreak
90 NanoViricides received ethics committee approval
87 World Health Organization estimated outbreak duration
84 Democratic Republic of the Congo reported 702 deaths
75 World Health Organization recommended prioritizing antibodies
70 Gilead Sciences donated drug
70 World Health Organization began trials
68 Democratic Republic of the Congo faced strike by health workers
+ 15 more actions View on Dashboard
cnt
The DRC is the epicenter of the outbreak, facing rapid spread, healthcare worker strikes, and rebel threats, straining its health system.
Importance 100.0 Sentiment -60.0
ngo
The WHO declared a PHEIC and is coordinating the response, including a treatment study for remdesivir and MBP134.
Importance 90.0 Sentiment -10.0
stock
NanoViricides is advancing NV-387 Oral Gummies for Ebola treatment, receiving DRC Pillar Committee approval, with potential for significant market impact if effective.
Importance 80.0 Sentiment 70.0
govactor
Africa CDC is intensifying international efforts to stop the outbreak, with its director warning of potential escalation.
Importance 70.0 Sentiment -10.0
stock
Gilead's remdesivir is being studied in a WHO-led trial for Bundibugyo Ebola, potentially expanding its use.
Importance 60.0 Sentiment 30.0
per
As Africa CDC director, Kaseya reported 1,031 deaths and called for intensified response.
Importance 50.0 Sentiment -10.0
priv
Mapp's MBP134 antibody cocktail is being tested in the WHO treatment study for Ebola.
Importance 50.0 Sentiment 30.0
cnt
Uganda has reported Ebola cases, increasing regional spread risk and requiring cross-border containment efforts.
Importance 40.0 Sentiment -30.0
per
As NanoViricides' president, Diwan highlighted NV-387's potential as an oral treatment for Ebola.
Importance 30.0 Sentiment 20.0
cnt
Rwanda-backed rebels in Goma complicate the response, but Rwanda itself is not directly affected.
Importance 30.0 Sentiment -20.0
cnt
South Sudan is at risk due to proximity to the outbreak epicenter in Ituri province.
Importance 20.0 Sentiment -20.0
priv
Om Sai CRO is supporting NanoViricides' clinical trial execution in DRC.
Importance 20.0 Sentiment 10.0
ngo
News agency reporting on the outbreak; not an actor in the event.
Importance 10.0 Sentiment 0.0
ngo
The Gates Foundation provides financial support for AP's global health coverage, not directly involved in outbreak response.
Importance 10.0 Sentiment 0.0
Democratic Republic of the Congo neighbor Uganda The Democratic Republic of the Congo shares a critical border with Uganda, currently defined by the cross-border spread
World Health Organization collaborator United States — Centers for Disease Control and Prevention The World Health Organization and the US Centers for Disease Control and Prevention collaborate closely to monitor and r
World Health Organization operator Uganda The World Health Organization operates a country office in Uganda, collaborating with the national government to manage
+ 11 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.